Business Context and Reporting Period
This Form 8-K is a current report filed by Eyenovia, Inc. (trading symbol: EYEN) on June 16, 2021. The filing reports on the results of the company's 2021 Annual Meeting of Stockholders held on the same date. Note: The request metadata references "HYPERION DEFI, INC.", but the source text explicitly identifies the registrant as Eyenovia, Inc.
Key Financial Metrics
This filing is a corporate governance report and does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The filing text does not provide a clear value for any financial indicators.
Material Changes and Corporate Actions
The filing details three specific matters submitted to a vote of security holders:
- Election of Directors: Stockholders elected eight individuals to the Board of Directors for a one-year term. Notably, nominees Fredric N. Eshelman and Ernest Mario received significant "withheld" votes (approximately 4.4 million shares each) compared to other nominees who received fewer than 350,000 withheld votes.
- Equity Plan Amendment: Stockholders approved an amendment to the 2018 Omnibus Stock Incentive Plan, reserving an additional 1,250,000 shares of common stock for issuance.
- Auditor Ratification: Stockholders ratified the appointment of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. It strictly reports the voting outcomes of the Annual Meeting.
Key Facts for Investor Verification
- Verify the identity of the registrant: The filing is for Eyenovia, Inc., not Hyperion DeFi, Inc.
- Review the voting results for directors Fredric N. Eshelman and Ernest Mario, as they received a high volume of withheld authority votes compared to other board members.
- Confirm the increase in the share reserve for the Equity Plan by 1,250,000 shares, which may impact future dilution.
- Check the definitive proxy statement filed on April 30, 2021, for detailed descriptions of the matters voted upon.